1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gelasco, A.
Lippard, S.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
Cl2 H6 N2 Pt
300.045
Cisplatin
diammine(dichloro)platinum
non-polymer
C10 H14 N5 O6 P
331.222
y
2'-DEOXYADENOSINE-5'-MONOPHOSPHATE
DNA linking
C9 H14 N3 O7 P
307.197
y
2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE
DNA linking
C10 H14 N5 O7 P
347.221
y
2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE
DNA linking
C10 H15 N2 O8 P
322.208
y
THYMIDINE-5'-MONOPHOSPHATE
DNA linking
N
1
N
PT
N
2
N
N
N
3
N
N
N
4
N
H
N
5
N
H
N
6
N
H
N
7
N
H
N
8
N
CL
N
9
N
CL
N
10
N
H
N
11
N
H
N
12
N
O
N
13
N
P
N
14
N
O
N
15
N
O
N
16
N
O
N
17
N
C
N
18
R
C
N
19
N
O
N
20
S
C
N
21
N
O
N
22
N
C
N
23
R
C
Y
24
N
N
Y
25
N
C
Y
26
N
N
Y
27
N
C
Y
28
N
C
N
29
N
N
Y
30
N
N
Y
31
N
C
Y
32
N
N
Y
33
N
C
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
N
H
N
41
N
H
N
42
N
H
N
43
N
H
N
44
N
H
N
45
N
H
N
46
N
H
N
47
N
H
N
48
N
O
N
49
N
P
N
50
N
O
N
51
N
O
N
52
N
O
N
53
N
C
N
54
R
C
N
55
N
O
N
56
S
C
N
57
N
O
N
58
N
C
N
59
R
C
N
60
N
N
N
61
N
C
N
62
N
O
N
63
N
N
N
64
N
C
N
65
N
N
N
66
N
C
N
67
N
C
N
68
N
H
N
69
N
H
N
70
N
H
N
71
N
H
N
72
N
H
N
73
N
H
N
74
N
H
N
75
N
H
N
76
N
H
N
77
N
H
N
78
N
H
N
79
N
H
N
80
N
H
N
81
N
H
N
82
N
O
N
83
N
P
N
84
N
O
N
85
N
O
N
86
N
O
N
87
N
C
N
88
R
C
N
89
N
O
N
90
S
C
N
91
N
O
N
92
N
C
N
93
R
C
Y
94
N
N
Y
95
N
C
Y
96
N
N
Y
97
N
C
N
98
N
C
N
99
N
O
N
100
N
N
N
101
N
C
N
102
N
N
N
103
N
N
Y
104
N
C
N
105
N
H
N
106
N
H
N
107
N
H
N
108
N
H
N
109
N
H
N
110
N
H
N
111
N
H
N
112
N
H
N
113
N
H
N
114
N
H
N
115
N
H
N
116
N
H
N
117
N
H
N
118
N
H
N
119
N
O
N
120
N
P
N
121
N
O
N
122
N
O
N
123
N
O
N
124
N
C
N
125
R
C
N
126
N
O
N
127
S
C
N
128
N
O
N
129
N
C
N
130
R
C
N
131
N
N
N
132
N
C
N
133
N
O
N
134
N
N
N
135
N
C
N
136
N
O
N
137
N
C
N
138
N
C
N
139
N
C
N
140
N
H
N
141
N
H
N
142
N
H
N
143
N
H
N
144
N
H
N
145
N
H
N
146
N
H
N
147
N
H
N
148
N
H
N
149
N
H
N
150
N
H
N
151
N
H
N
152
N
H
N
153
N
H
N
154
N
H
N
1
N
sing
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
sing
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
doub
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
sing
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
sing
Y
34
N
sing
Y
35
N
sing
Y
36
N
doub
N
37
N
sing
Y
38
N
sing
Y
39
N
sing
Y
40
N
doub
N
41
N
sing
Y
42
N
doub
N
43
N
sing
N
44
N
sing
Y
45
N
sing
Y
46
N
doub
N
47
N
sing
Y
48
N
sing
N
49
N
sing
N
50
N
sing
N
51
N
doub
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
sing
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
sing
N
67
N
sing
N
68
N
sing
N
69
N
sing
N
70
N
sing
N
71
N
sing
N
72
N
sing
N
73
N
sing
N
74
N
doub
N
75
N
sing
N
76
N
doub
N
77
N
sing
N
78
N
sing
N
79
N
sing
N
80
N
sing
N
81
N
doub
N
82
N
sing
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
doub
N
87
N
sing
N
88
N
sing
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
sing
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
sing
N
98
N
sing
N
99
N
sing
N
100
N
sing
N
101
N
sing
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
sing
Y
107
N
sing
Y
108
N
sing
Y
109
N
doub
N
110
N
sing
Y
111
N
sing
N
112
N
sing
Y
113
N
doub
N
114
N
doub
N
115
N
sing
N
116
N
sing
N
117
N
sing
N
118
N
sing
N
119
N
doub
N
120
N
sing
N
121
N
sing
N
122
N
sing
N
123
N
sing
N
124
N
sing
N
125
N
doub
N
126
N
sing
N
127
N
sing
N
128
N
sing
N
129
N
sing
N
130
N
sing
N
131
N
sing
N
132
N
sing
N
133
N
sing
N
134
N
sing
N
135
N
sing
N
136
N
sing
N
137
N
sing
N
138
N
sing
N
139
N
sing
N
140
N
sing
N
141
N
sing
N
142
N
sing
N
143
N
sing
N
144
N
sing
N
145
N
sing
N
146
N
sing
N
147
N
sing
N
148
N
doub
N
149
N
sing
N
150
N
sing
N
151
N
sing
N
152
N
doub
N
153
N
sing
N
154
N
sing
N
155
N
doub
N
156
N
sing
N
157
N
sing
N
158
N
sing
N
159
N
sing
US
Biochemistry
BICHAW
0033
0006-2960
37
9230
9239
10.1021/bi973176v
9649303
NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin.
1998
10.2210/pdb1a84/pdb
pdb_00001a84
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
CISPLATIN INTRASTRAND CROSS-LINKED DNA
3565.316
DNA D(CCTCTG*G*TCTCC)
1
syn
polymer
CISPLATIN INTRASTRAND CROSS-LINKED DNA
3761.468
DNA D(GGAGACCAGAGG)
1
syn
polymer
300.045
Cisplatin
1
syn
non-polymer
no
no
(DC)(DC)(DT)(DC)(DT)(DG)(DG)(DT)(DC)(DT)(DC)(DC)
CCTCTGGTCTCC
A
polydeoxyribonucleotide
no
no
(DG)(DG)(DA)(DG)(DA)(DC)(DC)(DA)(DG)(DA)(DG)(DG)
GGAGACCAGAGG
B
polydeoxyribonucleotide
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
5.075
1
19
A
1
B
24
-1.678
A_DC1:DG24_B
1
2.470
0.126
-0.327
-0.095
-6.510
1
19
A
2
B
23
-0.867
A_DC2:DG23_B
2
-6.609
0.263
-0.069
-0.116
4.523
1
20
A
3
B
22
2.427
A_DT3:DA22_B
3
-8.763
0.083
-0.484
-0.186
5.927
1
19
A
4
B
21
-1.899
A_DC4:DG21_B
4
7.761
0.062
-0.331
-0.088
-2.401
1
20
A
5
B
20
1.507
A_DT5:DA20_B
5
25.824
0.132
0.529
-0.240
33.274
1
19
A
6
B
19
15.784
A_DG6:DC19_B
6
-6.563
0.702
-0.669
-0.581
-1.050
1
19
A
7
B
18
-0.752
A_DG7:DC18_B
7
-9.684
-0.664
-0.126
-0.233
21.175
1
20
A
8
B
17
-2.357
A_DT8:DA17_B
8
-1.188
-0.106
-0.445
-0.082
8.307
1
19
A
9
B
16
1.406
A_DC9:DG16_B
9
-14.943
0.217
-0.549
-0.133
-10.506
1
20
A
10
B
15
-0.088
A_DT10:DA15_B
10
-6.205
-0.167
0.413
-0.137
14.907
1
19
A
11
B
14
-1.446
A_DC11:DG14_B
11
-8.118
0.318
-0.442
-0.118
-22.480
1
19
A
12
B
13
-1.889
A_DC12:DG13_B
12
18.772
0.383
0.186
-0.098
4.502
34.447
A
A
1
2
17.110
B
B
24
23
4.558
9.991
0.631
0.365
AA_DC1DC2:DG23DG24_BB
1
1.826
-3.127
32.960
-1.586
-0.662
2.323
23.374
A
A
2
3
23.980
B
B
23
22
3.045
9.443
-0.690
-1.219
AA_DC2DT3:DA22DG23_BB
2
-0.643
1.633
21.396
-5.769
1.514
3.848
32.869
A
A
3
4
-5.906
B
B
22
21
3.789
-3.323
-0.234
-0.875
AA_DT3DC4:DG21DA22_BB
3
-5.172
9.191
32.305
-0.876
-0.628
3.744
30.662
A
A
4
5
24.424
B
B
21
20
4.710
12.510
0.212
-1.235
AA_DC4DT5:DA20DG21_BB
4
-4.326
8.447
27.720
-5.692
-1.562
1.122
26.871
A
A
5
6
54.273
B
B
20
19
2.906
20.344
-0.094
-0.136
AA_DT5DG6:DC19DA20_BB
5
13.200
-35.214
11.660
-4.843
3.155
-0.049
42.819
A
A
6
7
85.858
B
B
19
18
4.510
42.348
-0.299
-0.376
AA_DG6DG7:DC18DC19_BB
6
-5.795
11.750
2.619
-6.202
-0.369
3.302
34.960
A
A
7
8
5.994
B
B
18
17
3.405
3.588
-0.706
0.129
AA_DG7DT8:DA17DC18_BB
7
3.982
-6.653
34.559
-0.343
1.795
3.779
40.845
A
A
8
9
0.999
B
B
17
16
3.777
0.697
0.345
-0.725
AA_DT8DC9:DG16DA17_BB
8
2.807
-4.025
40.747
-1.127
-0.137
4.358
33.454
A
A
9
10
-1.353
B
B
16
15
4.406
-0.777
-0.042
0.496
AA_DC9DT10:DA15DG16_BB
9
-4.752
8.283
33.116
1.034
-0.984
2.061
53.556
A
A
10
11
-36.456
B
B
15
14
3.114
-31.005
0.057
0.961
AA_DT10DC11:DG14DA15_BB
10
5.215
-6.132
43.919
2.792
0.227
3.497
43.038
A
A
11
12
53.944
B
B
14
13
5.671
34.458
0.977
0.115
AA_DC11DC12:DG13DG14_BB
11
-3.164
4.953
25.994
-5.937
-1.892
chem_comp_atom
chem_comp_bond
database_2
pdbx_database_status
struct_conn
struct_site
repository
Initial release
Version format compliance
Non-polymer description
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1998-11-25
1
1
2008-03-24
1
2
2011-07-13
1
3
2024-04-10
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_asym_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_asym_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1998-04-02
REL
CPT
Cisplatin
THE STRUCTURE WAS DETERMINED USING 2D 1H-1H NMR SPECTROSCOPY IN BOTH D2O AND H2O SOLUTIONS
LEAST RESTRAINT VIOLATION
1
1
2D1HNOESY
TOCSY
PECOSY
100 mM NACL
6.9
1
atm
288
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.
NOE-RESTRAINED REFINEMENT
D2O/H2O
BRUNGER
refinement
X-PLOR
structure solution
X-PLOR
structure solution
QUANTA
750
FRANCIS BITTER MAGNET LAB CUSTOM BUILT
FBML 750
CPT
1
3
CPT
CPT
13
A
C
1
n
1
DC
1
A
C
2
n
2
DC
2
A
T
3
n
3
DT
3
A
C
4
n
4
DC
4
A
T
5
n
5
DT
5
A
G
6
n
6
DG
6
A
G
7
n
7
DG
7
A
T
8
n
8
DT
8
A
C
9
n
9
DC
9
A
T
10
n
10
DT
10
A
C
11
n
11
DC
11
A
C
12
n
12
DC
12
A
G
13
n
1
DG
13
B
G
14
n
2
DG
14
B
A
15
n
3
DA
15
B
G
16
n
4
DG
16
B
A
17
n
5
DA
17
B
C
18
n
6
DC
18
B
C
19
n
7
DC
19
B
A
20
n
8
DA
20
B
G
21
n
9
DG
21
B
A
22
n
10
DA
22
B
G
23
n
11
DG
23
B
G
24
n
12
DG
24
B
author_defined_assembly
2
dimeric
A
DG
6
A
N7
DG
6
1_555
A
CPT
13
C
PT1
CPT
1_555
A
CPT
13
C
N1
CPT
1_555
179.9
A
DG
6
A
N7
DG
6
1_555
A
CPT
13
C
PT1
CPT
1_555
A
CPT
13
C
N2
CPT
1_555
89.8
A
CPT
13
C
N1
CPT
1_555
A
CPT
13
C
PT1
CPT
1_555
A
CPT
13
C
N2
CPT
1_555
90.1
A
DG
6
A
N7
DG
6
1_555
A
CPT
13
C
PT1
CPT
1_555
A
DG
7
A
N7
DG
7
1_555
90.1
A
CPT
13
C
N1
CPT
1_555
A
CPT
13
C
PT1
CPT
1_555
A
DG
7
A
N7
DG
7
1_555
90.0
A
CPT
13
C
N2
CPT
1_555
A
CPT
13
C
PT1
CPT
1_555
A
DG
7
A
N7
DG
7
1_555
179.7
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
H4'
OP1
DA
DG
15
16
1.48
1
B
B
H2''
OP2
DG
DG
23
24
1.57
1
A
A
H2''
OP2
DT
DC
10
11
1.60
1
A
DC
9
0.076
SIDE CHAIN
1
6.42
0.90
103.10
109.52
A
A
A
C4'
C3'
C2'
DC
DC
DC
1
1
1
N
1
1.97
0.30
108.30
110.27
A
A
A
O4'
C1'
N1
DC
DC
DC
1
1
1
N
1
3.99
0.30
108.30
112.29
A
A
A
O4'
C1'
N1
DC
DC
DC
2
2
2
N
1
2.98
0.30
108.30
111.28
A
A
A
O4'
C1'
N1
DT
DT
DT
3
3
3
N
1
-3.87
0.60
122.90
119.03
A
A
A
C6
C5
C7
DT
DT
DT
3
3
3
N
1
3.36
0.30
108.30
111.66
A
A
A
O4'
C1'
N1
DC
DC
DC
4
4
4
N
1
5.80
0.90
103.10
108.90
A
A
A
C4'
C3'
C2'
DT
DT
DT
5
5
5
N
1
3.88
0.50
106.80
110.68
A
A
A
O4'
C1'
C2'
DT
DT
DT
5
5
5
N
1
1.81
0.30
108.30
110.11
A
A
A
O4'
C1'
N9
DG
DG
DG
6
6
6
N
1
1.90
0.30
108.30
110.20
A
A
A
O4'
C1'
N9
DG
DG
DG
7
7
7
N
1
2.93
0.30
108.30
111.23
A
A
A
O4'
C1'
N1
DT
DT
DT
10
10
10
N
1
5.69
0.90
103.10
108.79
A
A
A
C4'
C3'
C2'
DC
DC
DC
11
11
11
N
1
3.22
0.50
106.80
110.02
A
A
A
O4'
C1'
C2'
DC
DC
DC
11
11
11
N
1
3.51
0.30
108.30
111.81
A
A
A
O4'
C1'
N1
DC
DC
DC
11
11
11
N
1
6.39
0.90
103.10
109.49
A
A
A
C4'
C3'
C2'
DC
DC
DC
12
12
12
N
1
3.21
0.50
106.80
110.01
A
A
A
O4'
C1'
C2'
DC
DC
DC
12
12
12
N
1
2.59
0.30
108.30
110.89
A
A
A
O4'
C1'
N1
DC
DC
DC
12
12
12
N
1
6.12
0.90
103.10
109.22
B
B
B
C4'
C3'
C2'
DG
DG
DG
13
13
13
N
1
4.69
0.50
113.10
117.79
B
B
B
N7
C8
N9
DG
DG
DG
13
13
13
N
1
-2.66
0.40
106.40
103.74
B
B
B
C8
N9
C4
DG
DG
DG
13
13
13
N
1
5.41
0.90
103.10
108.51
B
B
B
C4'
C3'
C2'
DG
DG
DG
14
14
14
N
1
4.37
0.50
113.10
117.47
B
B
B
N7
C8
N9
DG
DG
DG
14
14
14
N
1
-2.98
0.40
106.40
103.42
B
B
B
C8
N9
C4
DG
DG
DG
14
14
14
N
1
3.70
0.50
113.80
117.50
B
B
B
N7
C8
N9
DA
DA
DA
15
15
15
N
1
-3.15
0.40
105.80
102.65
B
B
B
C8
N9
C4
DA
DA
DA
15
15
15
N
1
4.69
0.30
108.30
112.99
B
B
B
O4'
C1'
N9
DG
DG
DG
16
16
16
N
1
4.22
0.50
113.10
117.32
B
B
B
N7
C8
N9
DG
DG
DG
16
16
16
N
1
-2.68
0.40
106.40
103.72
B
B
B
C8
N9
C4
DG
DG
DG
16
16
16
N
1
6.43
0.90
103.10
109.53
B
B
B
C4'
C3'
C2'
DA
DA
DA
17
17
17
N
1
3.07
0.30
108.30
111.37
B
B
B
O4'
C1'
N9
DA
DA
DA
17
17
17
N
1
3.60
0.50
113.80
117.40
B
B
B
N7
C8
N9
DA
DA
DA
17
17
17
N
1
5.58
0.90
103.10
108.68
B
B
B
C4'
C3'
C2'
DC
DC
DC
18
18
18
N
1
4.63
0.30
108.30
112.93
B
B
B
O4'
C1'
N1
DC
DC
DC
18
18
18
N
1
5.75
0.90
103.10
108.85
B
B
B
C4'
C3'
C2'
DC
DC
DC
19
19
19
N
1
2.35
0.30
108.30
110.65
B
B
B
O4'
C1'
N1
DC
DC
DC
19
19
19
N
1
3.32
0.30
108.30
111.62
B
B
B
O4'
C1'
N9
DA
DA
DA
20
20
20
N
1
3.75
0.50
113.80
117.55
B
B
B
N7
C8
N9
DA
DA
DA
20
20
20
N
1
-2.52
0.40
105.80
103.28
B
B
B
C8
N9
C4
DA
DA
DA
20
20
20
N
1
3.03
0.30
108.30
111.33
B
B
B
O4'
C1'
N9
DG
DG
DG
21
21
21
N
1
4.36
0.50
113.10
117.46
B
B
B
N7
C8
N9
DG
DG
DG
21
21
21
N
1
-2.67
0.40
106.40
103.73
B
B
B
C8
N9
C4
DG
DG
DG
21
21
21
N
1
2.73
0.30
108.30
111.03
B
B
B
O4'
C1'
N9
DA
DA
DA
22
22
22
N
1
3.63
0.50
113.80
117.43
B
B
B
N7
C8
N9
DA
DA
DA
22
22
22
N
1
-5.17
0.80
102.40
97.23
B
B
B
C3'
C2'
C1'
DG
DG
DG
23
23
23
N
1
3.39
0.30
108.30
111.69
B
B
B
O4'
C1'
N9
DG
DG
DG
23
23
23
N
1
4.39
0.50
113.10
117.49
B
B
B
N7
C8
N9
DG
DG
DG
23
23
23
N
1
-3.36
0.40
106.40
103.04
B
B
B
C8
N9
C4
DG
DG
DG
23
23
23
N
1
6.04
0.90
103.10
109.14
B
B
B
C4'
C3'
C2'
DG
DG
DG
24
24
24
N
1
3.09
0.50
106.80
109.89
B
B
B
O4'
C1'
C2'
DG
DG
DG
24
24
24
N
1
2.71
0.30
108.30
111.01
B
B
B
O4'
C1'
N9
DG
DG
DG
24
24
24
N
1
4.50
0.50
113.10
117.60
B
B
B
N7
C8
N9
DG
DG
DG
24
24
24
N
1
-2.71
0.40
106.40
103.69
B
B
B
C8
N9
C4
DG
DG
DG
24
24
24
N
1
A
A
C5'
C4'
DT
DT
8
8
0.048
0.007
1.512
1.560
N
1
A
A
C5
C7
DT
DT
10
10
0.038
0.006
1.496
1.534
N
1
A
A
C5'
C4'
DC
DC
12
12
0.059
0.007
1.512
1.571
N
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
NMR SOLUTION STRUCTURE OF A DNA DODECAMER DUPLEX CONTAINING A CIS-DIAMMINEPLATINUM(II) D(GPG) INTRASTRAND CROSS-LINK, THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN, 1 STRUCTURE
1
N
N
2
N
N
3
N
N
metalc
2.046
A
DG
6
A
N7
DG
6
1_555
A
CPT
13
C
PT1
CPT
1_555
metalc
2.051
A
DG
7
A
N7
DG
7
1_555
A
CPT
13
C
PT1
CPT
1_555
hydrog
WATSON-CRICK
A
DC
1
A
N3
DC
1
1_555
B
DG
24
B
N1
DG
12
1_555
hydrog
WATSON-CRICK
A
DC
1
A
N4
DC
1
1_555
B
DG
24
B
O6
DG
12
1_555
hydrog
WATSON-CRICK
A
DC
1
A
O2
DC
1
1_555
B
DG
24
B
N2
DG
12
1_555
hydrog
WATSON-CRICK
A
DC
2
A
N3
DC
2
1_555
B
DG
23
B
N1
DG
11
1_555
hydrog
WATSON-CRICK
A
DC
2
A
N4
DC
2
1_555
B
DG
23
B
O6
DG
11
1_555
hydrog
WATSON-CRICK
A
DC
2
A
O2
DC
2
1_555
B
DG
23
B
N2
DG
11
1_555
hydrog
WATSON-CRICK
A
DT
3
A
N3
DT
3
1_555
B
DA
22
B
N1
DA
10
1_555
hydrog
WATSON-CRICK
A
DT
3
A
O4
DT
3
1_555
B
DA
22
B
N6
DA
10
1_555
hydrog
WATSON-CRICK
A
DC
4
A
N3
DC
4
1_555
B
DG
21
B
N1
DG
9
1_555
hydrog
WATSON-CRICK
A
DC
4
A
N4
DC
4
1_555
B
DG
21
B
O6
DG
9
1_555
hydrog
WATSON-CRICK
A
DC
4
A
O2
DC
4
1_555
B
DG
21
B
N2
DG
9
1_555
hydrog
WATSON-CRICK
A
DT
5
A
N3
DT
5
1_555
B
DA
20
B
N1
DA
8
1_555
hydrog
WATSON-CRICK
A
DT
5
A
O4
DT
5
1_555
B
DA
20
B
N6
DA
8
1_555
hydrog
WATSON-CRICK
A
DG
6
A
N1
DG
6
1_555
B
DC
19
B
N3
DC
7
1_555
hydrog
WATSON-CRICK
A
DG
6
A
N2
DG
6
1_555
B
DC
19
B
O2
DC
7
1_555
hydrog
WATSON-CRICK
A
DG
6
A
O6
DG
6
1_555
B
DC
19
B
N4
DC
7
1_555
hydrog
WATSON-CRICK
A
DG
7
A
N1
DG
7
1_555
B
DC
18
B
N3
DC
6
1_555
hydrog
WATSON-CRICK
A
DG
7
A
N2
DG
7
1_555
B
DC
18
B
O2
DC
6
1_555
hydrog
WATSON-CRICK
A
DG
7
A
O6
DG
7
1_555
B
DC
18
B
N4
DC
6
1_555
hydrog
WATSON-CRICK
A
DT
8
A
N3
DT
8
1_555
B
DA
17
B
N1
DA
5
1_555
hydrog
WATSON-CRICK
A
DT
8
A
O4
DT
8
1_555
B
DA
17
B
N6
DA
5
1_555
hydrog
WATSON-CRICK
A
DC
9
A
N3
DC
9
1_555
B
DG
16
B
N1
DG
4
1_555
hydrog
WATSON-CRICK
A
DC
9
A
N4
DC
9
1_555
B
DG
16
B
O6
DG
4
1_555
hydrog
WATSON-CRICK
A
DC
9
A
O2
DC
9
1_555
B
DG
16
B
N2
DG
4
1_555
hydrog
WATSON-CRICK
A
DT
10
A
N3
DT
10
1_555
B
DA
15
B
N1
DA
3
1_555
hydrog
WATSON-CRICK
A
DT
10
A
O4
DT
10
1_555
B
DA
15
B
N6
DA
3
1_555
hydrog
WATSON-CRICK
A
DC
11
A
N3
DC
11
1_555
B
DG
14
B
N1
DG
2
1_555
hydrog
WATSON-CRICK
A
DC
11
A
N4
DC
11
1_555
B
DG
14
B
O6
DG
2
1_555
hydrog
WATSON-CRICK
A
DC
11
A
O2
DC
11
1_555
B
DG
14
B
N2
DG
2
1_555
hydrog
WATSON-CRICK
A
DC
12
A
N3
DC
12
1_555
B
DG
13
B
N1
DG
1
1_555
hydrog
WATSON-CRICK
A
DC
12
A
N4
DC
12
1_555
B
DG
13
B
O6
DG
1
1_555
hydrog
WATSON-CRICK
A
DC
12
A
O2
DC
12
1_555
B
DG
13
B
N2
DG
1
1_555
DNA
DEOXYRIBONUCLEIC ACID, CISPLATIN, DNA, DUPLEX, DODECAMER, HMG-DOMAIN INTERACTION
1A84
PDB
1
1A84
1A84
PDB
2
1A84
1
12
1A84
1
12
1A84
A
1
1
12
13
24
1A84
13
24
1A84
B
2
1
12
BINDING SITE FOR RESIDUE CPT A 13
A
CPT
13
Software
3
A
DT
5
A
DT
5
3
1_555
A
DG
6
A
DG
6
3
1_555
A
DG
7
A
DG
7
3
1_555
1
P 1